Relationships among norepinephrine levels, exercise capacity, and chronotropic responses in heart failure patients

Liza Grosman-Rimon1,2, Evan Wright3, Solomon Sabovich4

  • 1Lea and Benjamin Davidai Division of Cardiovascular Medicine and Surgery, The Lydia and Carol Kittner, Poriya Medical Center, affiliated with Azrieli Faculty of Medicine, Bar Ilan University, Lower Galilee, Tiberias, Israel. l.grosman.rimon@gmail.com.

Heart Failure Reviews
|March 24, 2022
PubMed

Insights

Heart failure patients experience poor exercise capacity due to chronotropic incompetence (CI). Elevated norepinephrine (NE) contributes to CI, impacting heart rate (HR) response during exercise.

Area of Science:

  • Cardiology
  • Exercise Physiology

Background:

  • Heart failure (HF) patients exhibit severe exercise intolerance.
  • Central abnormalities, including impaired cardiac function and chronotropic incompetence (CI), contribute to reduced exercise capacity in HF.
  • CI is characterized by an inadequate heart rate (HR) increase during exercise, often linked to sympathetic nervous system (SNS) activation and elevated norepinephrine (NE).

Purpose of the Study:

  • To discuss the role of elevated norepinephrine (NE) in altering chronotropic responses in heart failure (HF) patients.
  • To examine the impact of NE on exercise capacity in HF.
  • To propose future research directions for treating CI.

Main Methods:

  • Literature review and discussion of pathophysiological mechanisms.
  • Analysis of the relationship between NE, CI, and exercise intolerance.
  • Exploration of potential therapeutic interventions.

Main Results:

  • Elevated NE levels are implicated in the development of CI in HF patients.
  • CI contributes significantly to impaired exercise capacity in HF.
  • Factors like beta-adrenergic receptor downregulation and beta-blocker use can influence CI.

Conclusions:

  • Elevated NE plays a crucial role in chronotropic incompetence and reduced exercise capacity in HF.
  • Future research should investigate rate-adaptive pacing as a potential treatment for CI in HF.
  • Rate-adaptive pacing should aim to improve exercise capacity without exacerbating sympathetic nervous system activation.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
82
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
452
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
777
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
156
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
833